Literature DB >> 32095659

ADVANCED MULTIMODAL NANOSYSTEM : THE FUTURE MEDICINE.

Subhra Mandal1.   

Abstract

Entities:  

Year:  2016        PMID： 32095659      PMCID： PMC7039624          DOI： 10.22580/2016/iscinote1.1aa

Source DB:  PubMed          Journal:  Isci Notes        ISSN： 2456-9577


× No keyword cloud information.
  9 in total

Review 1.  Theranostic nanoparticles engineered for clinic and pharmaceutics.

Authors:  Xiaowei Ma; Yuliang Zhao; Xing-Jie Liang
Journal:  Acc Chem Res       Date:  2011-07-06       Impact factor: 22.384

Review 2.  Drug-associated renal dysfunction and injury.

Authors:  Devasmita Choudhury; Ziauddin Ahmed
Journal:  Nat Clin Pract Nephrol       Date:  2006-02

Review 3.  Nanoparticles, Neurotoxicity and Neurodegenerative Diseases.

Authors:  Gohar Mushtaq; Jalaluddin A Khan; Ebenezer Joseph; Mohammad A Kamal
Journal:  Curr Drug Metab       Date:  2015       Impact factor: 3.731

Review 4.  The big picture on nanomedicine: the state of investigational and approved nanomedicine products.

Authors:  Michael L Etheridge; Stephen A Campbell; Arthur G Erdman; Christy L Haynes; Susan M Wolf; Jeffrey McCullough
Journal:  Nanomedicine       Date:  2012-06-06       Impact factor: 5.307

5.  Advances in cancer nanomedicine.

Authors:  Lin-Tao Cai; Zong-Hai Sheng
Journal:  Cancer Biol Med       Date:  2015-09       Impact factor: 4.248

Review 6.  Nanopharmaceuticals (part 1): products on the market.

Authors:  Volkmar Weissig; Tracy K Pettinger; Nicole Murdock
Journal:  Int J Nanomedicine       Date:  2014-09-15

Review 7.  Self-assembling protein nanoparticles in the design of vaccines.

Authors:  Jacinto López-Sagaseta; Enrico Malito; Rino Rappuoli; Matthew J Bottomley
Journal:  Comput Struct Biotechnol J       Date:  2015-11-26       Impact factor: 7.271

Review 8.  Drug delivery and nanoparticles:applications and hazards.

Authors:  Wim H De Jong; Paul J A Borm
Journal:  Int J Nanomedicine       Date:  2008

Review 9.  Adherence and health care costs.

Authors:  Aurel O Iuga; Maura J McGuire
Journal:  Risk Manag Healthc Policy       Date:  2014-02-20
  9 in total
  2 in total

1.  Long-acting parenteral combination antiretroviral loaded nano-drug delivery system to treat chronic HIV-1 infection: A humanized mouse model study.

Authors:  Subhra Mandal; Guobin Kang; Pavan Kumar Prathipati; Wenjin Fan; Qingsheng Li; Christopher J Destache
Journal:  Antiviral Res       Date:  2018-06-06       Impact factor: 5.970

2.  A Concept Evaluation Study of a New Combination Bictegravir plus Tenofovir Alafenamide Nanoformulation with Prolonged Sustained-Drug-Release Potency for HIV-1 Preexposure Prophylaxis.

Authors:  Subhra Mandal; Pavan Kumar Prathipati; Shawnalyn W Sunagawa; Christopher J Destache
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.938
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.